PAT随机临床试验:全膝关节置换与髌股关节置换治疗严重孤立性髌股关节炎的比较
这项在NHS教学医院开展的实用型、单中心、双盲随机对照试验纳入64例严重孤立性髌股关节炎患者,比较全膝关节置换(TKA)与髌股关节置换(PFA)术后12个月的功能性膝关节评分、生活质量评估和并发症。结果显示12个月时WOMAC功能评分无统计学显著差异(调整后平均差-1.2,95%CI -9.19至6.80;p=0.765),次要结局无临床显著差异,并发症率相当,24和60个月OKS、满意度及无痛年数亦无统计学显著差异。
要点
- 严重孤立性髌股关节炎患者中,PFA与TKA术后12个月WOMAC功能评分无统计学显著差异。
- 两组次要结局无临床显著差异,并发症率相当(PFA组浅表手术部位感染4例 vs TKA组5例)。
- 24和60个月OKS、自报满意度及无痛年数无统计学显著差异。
核心结论
- 在严重孤立性髌股关节炎患者中,PFA与TKA在12个月功能结局及中期结局方面相似。
研究设计与样本
- 实用型、单中心、双盲、平行两组、优效性随机临床试验,在NHS教学医院开展,把握度80%,纳入64例严重孤立性髌股关节炎患者。
主要发现
- 12个月WOMAC功能评分调整后平均差为-1.2(95%CI -9.19至6.80;p=0.765),无统计学显著差异。
- 次要结局无临床显著差异。
- 并发症率相当:PFA组浅表手术部位感染4例,TKA组5例。
- 24和60个月OKS评分、自报满意度评分及无痛年数无统计学显著差异。
临床怎么用
- 对于严重孤立性髌股关节炎,PFA可作为与TKA功能结局相似的术式选择,需结合患者具体情况决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: A pragmatic, single-centre, double-blind randomized clinical trial was conducted in a NHS teaching hospital to evaluate whether there is a difference in functional knee scores, quality-of-life outcome assessments, and complications at one-year after intervention between total knee arthroplasty (TKA) and patellofemoral arthroplasty (PFA) in patients with severe isolated patellofemoral arthritis. METHODS: This parallel, two-arm, superiority trial was powered at 80%, and involved 64 patients with severe isolated patellofemoral arthritis. The primary outcome measure was the functional section of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score at 12 months. Secondary outcomes were the full 24-item WOMAC, Oxford Knee Score (OKS), American Knee Society Score (AKSS), EuroQol five dimension (EQ-5D) quality-of-life score, the University of California, Los Angeles (UCLA) Physical Activity Rating Scale, and complication rates collected at three, six, and 12 months. For longer-term follow-up, OKS, EQ-5D, and self-reported satisfaction score were collected at 24 and 60 months. RESULTS: Among 64 patients who were randomized, five patients did not receive the allocated intervention, three withdrew, and one declined the intervention. There were no statistically significant differences in the patients' WOMAC function score at 12 months (adjusted mean difference, -1.2 (95% confidence interval -9.19 to 6.80); p = 0.765). There were no clinically significant differences in the secondary outcomes. Complication rates were comparable (superficial surgical site infections, four in the PFA group versus five in the TKA group). There were no statistically significant differences in the patients' OKS score at 24 and 60 months or self-reported satisfaction score or pain-free years. CONCLUSION: Among patients with severe isolated patellofemoral arthritis, this study found similar functional outcome at 12 months and mid-term in the use of PFA compared with TKA. Cite this article: Bone Joint J 2020;102-B(3):310-318.
引用
- Joseph MN, Achten J, Parsons NR, et al. The PAT randomized clinical trial. Bone Joint J. 2020. PMID: 32114806. doi:10.1302/0301-620X.102B3.BJJ-2019-0723.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。